---
figid: PMC12141126__109_2025_2539_Fig1_HTML
figtitle: Mechanistic illustration of endothelial dysfunction in rheumatoid arthritis
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12141126
filename: 109_2025_2539_Fig1_HTML.jpg
figlink: /pmc/articles/PMC12141126/figure/F1/
number: F1
caption: Mechanistic illustration of endothelial dysfunction in rheumatoid arthritis.
  Inflammatory cytokines, particularly TNF-α released from inflamed joints, promote
  oxidative stress and increase oxidized LDL (oxLDL). This activates the LOX1–NFκB–Arg2
  signaling pathway, leading to ARG2 upregulation and eNOS uncoupling, resulting in
  decreased nitric oxide (NO) bioavailability. The reduction in NO impairs endothelial
  function, as indicated by increased soluble VCAM- 1, MCP- 1, ADMA, and intima-media
  thickness (IMT). These changes collectively contribute to reduced vasodilation,
  vascular stiffness, plaque formation, and a heightened cardiovascular disease risk
  in RA patients
papertitle: 'Exploring endothelial dysfunction in major rheumatic diseases: current
  trends and future directions'
reftext: Arshiya S. Anwar Husaini, et al. J Mol Med (Berl). 2025 Apr 14;103(6).
year: '2025'
doi: 10.1007/s00109-025-02539-8
journal_title: Journal of Molecular Medicine (Berlin, Germany)
journal_nlm_ta: J Mol Med (Berl)
publisher_name: .na.character
keywords: Rheumatic diseases | Endothelial dysfunction | Chronic inflammation | Cardiovascular
  diseases | Immune system dysregulation
automl_pathway: 0.9428786
figid_alias: PMC12141126__F1
figtype: Figure
redirect_from: /figures/PMC12141126__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12141126__109_2025_2539_Fig1_HTML.html
  '@type': Dataset
  description: Mechanistic illustration of endothelial dysfunction in rheumatoid arthritis.
    Inflammatory cytokines, particularly TNF-α released from inflamed joints, promote
    oxidative stress and increase oxidized LDL (oxLDL). This activates the LOX1–NFκB–Arg2
    signaling pathway, leading to ARG2 upregulation and eNOS uncoupling, resulting
    in decreased nitric oxide (NO) bioavailability. The reduction in NO impairs endothelial
    function, as indicated by increased soluble VCAM- 1, MCP- 1, ADMA, and intima-media
    thickness (IMT). These changes collectively contribute to reduced vasodilation,
    vascular stiffness, plaque formation, and a heightened cardiovascular disease
    risk in RA patients
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNF
  - FOXG1
  - FOXH1
  - FOXM1
  - FOXQ1
  - FOXS1
  - FOXA1
  - FOXA2
  - FOXA3
  - FOXB1
  - FOXB2
  - FOXC1
  - FOXC2
  - FOXD1
  - FOXD2
  - FOXD3
  - FOXD4
  - FOXE1
  - FOXE3
  - FOXF1
  - FOXF2
  - FOXI1
  - FOXI2
  - FOXI3
  - FOXJ1
  - FOXJ2
  - FOXJ3
  - FOXK1
  - FOXK2
  - FOXL1
  - FOXL2
  - FOXN1
  - FOXN2
  - FOXN3
  - FOXN4
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - FOXP1
  - FOXP2
  - FOXP3
  - FOXP4
  - FOXR1
  - FOXR2
  - FOXD4L1
  - FOXD4L3
  - FOXD4L4
  - FOXD4L5
  - FOXD4L6
  - NBL1
  - NOS3
  - ENO4
  - ARG2
  - CCL2
  - ARTHRITIS
  - RHEUMATOID ARTHRITIS
---
